Cytra-2 Oral Solution and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Cytra-2 Oral Solution and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: citric acid / sodium citrate
Brand name: Bicitra, Cytra-2, Liqui-Dual Citra, Oracit, Shohl's Solution, Virtrate-2
Synonyms: Citric acid and sodium citrate, Sodium Citrate and Citric Acid
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cytra-2 Oral Solution-Insulin degludec
- Cytra-2 Oral Solution-Insulin Degludec (U-100) Prefilled Pens
- Cytra-2 Oral Solution-Insulin Degludec (U-100) Vials
- Cytra-2 Oral Solution-Insulin Degludec (U-200) Prefilled Pens
- Cytra-2 Oral Solution-Insulin degludec and liraglutide
- Cytra-2 Oral Solution-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Cytra-3
- Insulin aspart, recombinant Subcutaneous-Cytra-3 Oral Syrup
- Insulin aspart, recombinant Subcutaneous-Cytra-K
- Insulin aspart, recombinant Subcutaneous-Cytra-K (Potassium Citrate and Citric Acid Powder Pack)
- Insulin aspart, recombinant Subcutaneous-Cytra-K (Potassium Citrate and Citric Acid Solution)